medigraphic.com
Colegio de Medicina Interna de México.

2015, Number 5

<< Back Next >>

Med Int Mex 2015; 31 (5)

Severe sepsis secondary to Chryseobacterium indologenes bacteremia: the first case reported in Mexico

Carrillo-Esper R, Peña-Pérez CA, Neri-Maldonado R, Flores-Rivera OI, de la Torre-León T, Pérez-Calatayud A, Meza-Márquez JM, Alonso-Martínez D

Language: Spanish
References: 18
Page: 633-636
PDF size: 479.10 Kb.


ABSTRACT

Introduction: We report the first isolated case in Mexico of infection by Chryseobacterium indologenes, an emerging pathogen in immunocompromised patients.
Case presentation: The examined case was a 59-year-old male who had been diagnosed with non-Hodgkin lymphoma, had received a bone marrow transplant, and had been hospitalized for 21 days. This patient presented with evidence of a systemic inflammatory response, and C. indologenes was identified in his blood culture. He exhibited an adequate clinical response to treatment with levofloxacin.
Conclusions: C. indologenes is an emerging pathogen in hospital contexts; this pathogen predominantly affects immunocompromised patients who experience prolonged hospital stays and receive extended antibiotic therapy.


REFERENCES

  1. Chou DW, Wu SL, Lee CT, Tai FT, Yu WL. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit. Jpn J Infect Dis 2011;64:520-524.

  2. Lin YT, Jeng YY, Lin ML, Yu KW, Wang FD, Liu CY. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010;43:498-505.

  3. Vandamme P, Bernardet JF, Segers P, Kersters K, Holmes B. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int J Syst Bacteriol 1994;44:827-31.

  4. Thong ML, Puthucheary SD, Lee EL. Flavobacterium meningosepticum infection: an epidemiologic study in a newborn nursery. J Clin Pathol 1981;34(4):429-33.

  5. Ceyhan M, Yildirim I, Tekeli A, Yurdakok M, Us E, Altun B, et al. A Chryseibacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. Am J Infect Control 2008;36(6):453-57.

  6. Hung PP, Lin YH, Lin CF, Liu MF, Shi ZY. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality. J Microbiol Immunol Infect 2008;41(2):137-44

  7. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001;7:391-393.

  8. Yasmin S, García G, Sylvester T, Sunenshine R. Chryseobacterium indologenes in a woman with metastatic breast cancer in the United States of America: a case report. J Med Case Rep 2013;7(1):190.

  9. Ramos-Esteban JC, Bamba S, Jeng BH. Treatment of multidrug-resistant Flavobacterium indologenes keratitis with trimethoprim-sulfamethoxazole. Cornea 2008;27(9):1074-1076.

  10. Sakurada ZA. Chryseobacterium indologenes. Rev Chilena Infectol 2008;25(6):446.

  11. Hsueh PR, Hsiue TR, Wu JJ, Teng LJ, Ho SW, Hsieh WC, Luh KT. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996;23(3):550-5.

  12. Nulen E, Bussels B, Bols A, Gordts B, Van Landuyt HW . Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001;7:391-393.

  13. Green BT, Nolan PE. Cellulitis and bacteraemia due to Chryseobacterium indologenes. J Infect 2001;42: 219-220.

  14. Akay M, Gunduz E, Gulbas Z. Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient. Bone Marrow Transplant 2006;37:435-436.

  15. Chen FL, Wang GC, Teng SO, Ou TY, Yu FL, Lee WS. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect 2013;46(6):425-32.

  16. Guiu A, Buendía B, Llorca L, Goméz R, Girón R. Chryseobacterium spp. ¿Nuevo patógeno oportunista asociado a fibrosis quística? Enferm Infecc Microbiol Clin 2014;32(8):497-501.

  17. Calderón G, García E, Rojas P, García E, Rosso M, Losada A. Chryseobacterium indologenes infection in a newborn: a case report. J Med Case Rep 2011;5:10.

  18. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997–2001). J Clin Microbiol 2004;42:445-448.




2020     |     www.medigraphic.com